Launch One Acquisition Corp. Class A Ordinary shares
LPAALaunch One Acquisition Corp. Class A Ordinary shares (LPAA) is a special purpose acquisition company (SPAC) formed to identify and acquire a target business, typically in a specified industry or sector. As a blank check company, LPAA provides public investors with the opportunity to participate in the potential growth and development of the eventual operating company through the acquisition process.
$10.53 -0.01 (-0.09%)
Company News
Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
Minovia Therapeutics received FDA Orphan Drug Designation for MNV-201, a novel cell therapy targeting Myelodysplastic Syndrome (MDS), and announced a planned business combination with Launch One Acquisition Corp.
